Hudson Bay Capital Management’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-13,636
Closed -$61.6K 717
2023
Q4
$61.6K Hold
13,636
﹤0.01% 588
2023
Q3
$48.8K Hold
13,636
﹤0.01% 647
2023
Q2
$50.3K Sell
13,636
-592,847
-98% -$2.2M ﹤0.01% 680
2023
Q1
$2.01M Sell
606,483
-1,056,299
-64% -$3.65M 0.02% 525
2022
Q4
$6.45M Sell
1,662,782
-354,483
-18% -$1.09M 0.08% 279
2022
Q3
$4.9M Sell
2,017,265
-133,307
-6% -$320K 0.05% 430
2022
Q2
$4.26M Sell
2,150,572
-150,000
-7% -$295K 0.04% 496
2022
Q1
$4.21M Buy
+2,300,572
New +$3.59M 0.06% 432
2020
Q4
Sell
-110,000
Closed -$263K 584
2020
Q3
$263K Sell
110,000
-135,000
-55% -$370K ﹤0.01% 481
2020
Q2
$717K Buy
+245,000
New +$704K 0.01% 395

Other funds holding ADMA